Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

He Xian

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Nature Chemistry|January 7, 2026
Rethinking sustainable pathways for PFASHe Xian, Xuemei Li, Cheng Zhang
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi = Chinese Journal of Parasitology & Parasitic Diseases|August 27, 2018
[Malaria Incidence and Control in Baoshan City during the Twelfth Five-Year Plan Period]Jia-quan Li, He-xian Yang
Methods in Molecular Biology (Clifton, N.J.)|June 26, 2009
Guided selection methods through chain shufflingBao Guo-Qiang, He Xian-Li
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi = Chinese Journal of Parasitology & Parasitic Diseases|December 18, 2015
[Analysis of Time Distribution of Malaria Incidence in Baoshan City During 1990-2014]Jia-quan Li, He-xian Yang
Pharmaceutics|February 25, 2023
Nanobiotechnology-Enabled mRNA StabilizationHe Xian, Yue Zhang, Chengzhong Yu, et al.
Microbial Cell Factories|February 3, 2021
Fine tuning the glycolytic flux ratio of EP-bifido pathway for mevalonate production by enhancing glucose-6-phosphate dehydrogenase (Zwf) and CRISPRi suppressing 6-phosphofructose kinase (PfkA) in Escherichia coliYing Li, He Xian, Ya Xu, et al.
Nano Letters|April 2, 2024
A Pioglitazone Nanoformulation Designed for Cancer-Associated Fibroblast Reprogramming and Cancer TreatmentShevanuja Theivendran, He Xian, Jingjing Qu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 21, 2023
C-type lectin Mincle initiates IL-17-mediated inflammation in acute exacerbations of idiopathic pulmonary fibrosisChen Tao, He Xian, Zhou Nian-Yu, et al.
Cancer Science|July 16, 2015
ERGIC3, which is regulated by miR-203a, is a potential biomarker for non-small cell lung cancerQing-Hai Lin, Kui-Dong Zhang, He-Xian Duan, et al.
Pharmaceutics|March 29, 2023
Mesoporous Organosilica Nanoparticles with Tetrasulphide Bond to Enhance Plasmid DNA DeliveryYue Zhang, He Xian, Ekaterina Strounina, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Nature Chemistry|January 7, 2026
Rethinking sustainable pathways for PFASHe Xian, Xuemei Li, Cheng Zhang
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi = Chinese Journal of Parasitology & Parasitic Diseases|August 27, 2018
[Malaria Incidence and Control in Baoshan City during the Twelfth Five-Year Plan Period]Jia-quan Li, He-xian Yang
Methods in Molecular Biology (Clifton, N.J.)|June 26, 2009
Guided selection methods through chain shufflingBao Guo-Qiang, He Xian-Li
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi = Chinese Journal of Parasitology & Parasitic Diseases|December 18, 2015
[Analysis of Time Distribution of Malaria Incidence in Baoshan City During 1990-2014]Jia-quan Li, He-xian Yang
Pharmaceutics|February 25, 2023
Nanobiotechnology-Enabled mRNA StabilizationHe Xian, Yue Zhang, Chengzhong Yu, et al.
Microbial Cell Factories|February 3, 2021
Fine tuning the glycolytic flux ratio of EP-bifido pathway for mevalonate production by enhancing glucose-6-phosphate dehydrogenase (Zwf) and CRISPRi suppressing 6-phosphofructose kinase (PfkA) in Escherichia coliYing Li, He Xian, Ya Xu, et al.
Nano Letters|April 2, 2024
A Pioglitazone Nanoformulation Designed for Cancer-Associated Fibroblast Reprogramming and Cancer TreatmentShevanuja Theivendran, He Xian, Jingjing Qu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 21, 2023
C-type lectin Mincle initiates IL-17-mediated inflammation in acute exacerbations of idiopathic pulmonary fibrosisChen Tao, He Xian, Zhou Nian-Yu, et al.
Cancer Science|July 16, 2015
ERGIC3, which is regulated by miR-203a, is a potential biomarker for non-small cell lung cancerQing-Hai Lin, Kui-Dong Zhang, He-Xian Duan, et al.
Pharmaceutics|March 29, 2023
Mesoporous Organosilica Nanoparticles with Tetrasulphide Bond to Enhance Plasmid DNA DeliveryYue Zhang, He Xian, Ekaterina Strounina, et al.
Pageof 3